CAMKK2 and neoplasm: Broad immunophenotyping of the TME showed that the number of tumor-infiltrating lymphoid and myeloid cells, however, was not significantly altered by CaMKK2 deficiency (Supplementary Fig. 1g), suggesting it may instead be phenotypic or localization differences in the immune compartment that promote survival in the absence of CaMMK2.